Benserazide-induced gynaecomastia.
Fredericks
B D
BD
Lepre
F
F
D000368:Aged; D000978:Antiparkinson Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001545:Benserazide / Q000009:adverse effects* / Q000627:therapeutic use; D006177:Gynecomastia / Q000139:chemically induced*; D006801:Humans; D006966:Hyperprolactinemia / Q000139:chemically induced*; D008297:Male; D010300:Parkinson Disease / Q000188:drug therapy*; D011388:Prolactin / Q000097:blood
D000978:Antiparkinson Agents; D001545:Benserazide; D011388:Prolactin